Unveils Lp(a) Genetic Risk Insights: ASHG 2025 Highlights

Discover Helix's pioneering research on cardiovascular risk prediction through genetically predicted Lp(a) levels, presented at ASHG 2025. Our team has identified crucial genetic markers that could revolutionize cardiovascular risk assessment. Download our exclusive summary to access innovative data on how Lp(a) genetic variations influence cardiovascular complication risks. Stay at the forefront of genomic medicine and contribute to advancing personalized cardiovascular prevention strategies. Get your free copy of our groundbreaking ASHG presentation highlights now.